How prostate cancer raises the risk of suffering blood clots which can lead to DVT

Prostate cancer patients have double the risk of suffering blood clots which can lead to DVT, say researchers.

The risk is greatest for those undergoing hormone therapy for the disease, and in younger men with it at an advanced stage.

Blood clots are a known hazard from cancer, for reasons that are not clear, but a ten-year study is the first to demonstrate the link with prostate cancer.

Prostate cancer

Prostate cancer patients double their chances of suffering blood clots which can lead to DVT

Scientists looked at more than 76,000 Swedish patients who had received curative treatment, or hormone therapy, or were being monitored without treatment.

All were found to be at higher risk of blood clotting than men in the general population.

The two main types of clots linked to prostate cancer were deep vein thrombosis (DVT), which chiefly affects the legs, and pulmonary embolism, a potentially lethal lung clot.

Hormone therapy patients were two-and-a-half times more likely to suffer a DVT and nearly twice as much at risk of a pulmonary embolism, says a report in the The Lancet Oncology.

The raised risk of clots could be linked to the cancer itself, or treatment, or both, said the researchers, led by Dr Mieke Van Hemelrijck, of King's College London.

Each year 35,000 Britons are diagnosed with prostate cancer.


No comments have so far been submitted. Why not be the first to send us your thoughts, or debate this issue live on our message boards.

We are no longer accepting comments on this article.

Who is this week's top commenter? Find out now